Norges Bank Takes $135.74 Million Position in The Clorox Company $CLX

Norges Bank purchased a new stake in The Clorox Company (NYSE:CLX) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 1,346,173 shares of the company’s stock, valued at approximately $135,735,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Van ECK Associates Corp raised its position in Clorox by 93.9% in the 3rd quarter. Van ECK Associates Corp now owns 2,709,972 shares of the company’s stock worth $334,139,000 after purchasing an additional 1,312,471 shares during the period. Invesco Ltd. lifted its stake in Clorox by 23.1% in the third quarter. Invesco Ltd. now owns 3,995,590 shares of the company’s stock worth $492,656,000 after purchasing an additional 750,415 shares during the last quarter. Northwestern Mutual Wealth Management Co. boosted its position in shares of Clorox by 6,907.9% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 749,703 shares of the company’s stock valued at $75,593,000 after buying an additional 739,005 shares during the period. Worldquant Millennium Advisors LLC bought a new position in shares of Clorox during the second quarter valued at approximately $71,856,000. Finally, Two Sigma Investments LP grew its stake in shares of Clorox by 33.8% during the third quarter. Two Sigma Investments LP now owns 1,740,175 shares of the company’s stock valued at $214,564,000 after buying an additional 439,797 shares during the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Insider Transactions at Clorox

In other Clorox news, Director Pierre R. Breber purchased 5,000 shares of the firm’s stock in a transaction on Tuesday, May 5th. The stock was bought at an average cost of $85.82 per share, for a total transaction of $429,100.00. Following the completion of the purchase, the director owned 18,000 shares in the company, valued at $1,544,760. This represents a 38.46% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.63% of the stock is owned by corporate insiders.

Clorox Trading Up 1.2%

CLX opened at $89.55 on Friday. The company has a current ratio of 0.84, a quick ratio of 0.65 and a debt-to-equity ratio of 27.03. The firm has a market cap of $10.83 billion, a price-to-earnings ratio of 14.54, a PEG ratio of 0.46 and a beta of 0.56. The Clorox Company has a 12 month low of $84.70 and a 12 month high of $132.03. The stock has a fifty day moving average price of $97.16 and a 200-day moving average price of $105.39.

Clorox (NYSE:CLX) last posted its earnings results on Thursday, April 30th. The company reported $1.64 EPS for the quarter, beating analysts’ consensus estimates of $1.55 by $0.09. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The company had revenue of $1.67 billion during the quarter, compared to analysts’ expectations of $1.67 billion. During the same quarter in the prior year, the company posted $1.45 earnings per share. Clorox’s revenue for the quarter was up .1% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. As a group, equities research analysts anticipate that The Clorox Company will post 5.61 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

CLX has been the topic of a number of recent analyst reports. Citigroup reduced their target price on Clorox from $110.00 to $97.00 and set a “neutral” rating on the stock in a research note on Friday, May 1st. Zacks Research cut shares of Clorox from a “hold” rating to a “strong sell” rating in a report on Tuesday, May 12th. Evercore reaffirmed an “underperform” rating and issued a $110.00 price target on shares of Clorox in a research note on Friday, May 1st. JPMorgan Chase & Co. decreased their price objective on shares of Clorox from $99.00 to $95.00 and set an “underweight” rating for the company in a report on Friday, May 1st. Finally, Morgan Stanley lowered their price objective on shares of Clorox from $110.00 to $97.00 and set an “equal weight” rating for the company in a research report on Friday, May 1st. One research analyst has rated the stock with a Buy rating, eleven have given a Hold rating and five have given a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Reduce” and an average price target of $103.40.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.